Clark Eliana Insider Trades

Insider Trading History

Track insider trading activity for Clark Eliana. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.38M 93,864 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.37k 607 shares
$15.44
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.39M 94,471 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$246k 17,858 shares
$13.78
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.28M 87,118 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$87.6k 9,515 shares
$9.21
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.41M 95,369 shares
Last Trade
Jul 01, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$10k 1,022 shares
$9.82
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.41M 95,369 shares
Last Trade
Mar 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.1k 679 shares
$8.99
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.42M 96,048 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$461k 45,714 shares
$10.09
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $945k 64,048 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$90.4k 7,422 shares
$12.18
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.05M 71,470 shares
Last Trade
Jan 02, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$6.69k 556 shares
$12.03
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.05M 71,470 shares
Last Trade
Jul 01, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.29k 405 shares
$22.93
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.05M 71,470 shares
Last Trade
Mar 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$20k 605 shares
$32.99
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $1.06M 72,075 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.47M 45,072 shares
$32.66
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $666k 45,146 shares
Last Trade
Jan 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$136k 4,608 shares
$29.50
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $666k 45,146 shares
Last Trade
Jul 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$14.6k 360 shares
$40.51
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $666k 45,146 shares
Last Trade
Jun 20, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$225k 5,000 shares
$45.00
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $740k 50,146 shares
Last Trade
Jun 20, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$218k 5,000 shares
$43.62
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $852k 57,750 shares
Last Trade
Jun 20, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$218k 5,000 shares
$43.62
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $666k 45,146 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 34,674 shares
$40.75
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $213k 14,473 shares
Last Trade
Jan 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$63k 1,692 shares
$37.21
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $238k 16,165 shares
Last Trade
Jan 03, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.96k 231 shares
$34.48
$14.75
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, Chief Technical Officer
Holding Value $238k 16,165 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.23M 15,395 shares
$79.85
$14.75

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up